Pramil Tiwari, PhD

Prof. & Head
National Institute of Pharmaceutical Education and Research, Mohali India, India

Poster(s):

• (C-046) Epidemiology and Risk Factors for Antimicrobial Resistance in ICU Patients with Acinetobacter baumannii Infections: A Retrospective Study in an Indian Hospital
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-086) Evaluating the Impact of GAAT Criteria on the Development of Antimicrobial Resistance in ICU Patients Receiving Parenteral Antimicrobial Therapy
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-022) Exploring the prognostic importance of serum phosphate levels and hyperphosphatemia on mortality and composite endpoints in non-dialysis CKD patients: a real-world evidence study
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-020) Incidence and Risk Factors of chemotherapy-induced Nephrotoxicity in Cancer Patients with Proper Hydration and Dose Adjustments: A Prospective Hospital-based Study
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET